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A Perfect Message: RNA Surveillance Minireview
and Nonsense-Mediated Decay
become immobile. These findings led to the suggestion
that NMD serves as an mRNA surveillance mechanism
to eliminate mRNAs encoding truncated polypeptides
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Meyerhofstrasse 1 that could act in a dominant-negative fashion (Figure 1).
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nonfunctional polypeptides is suppressed by NMD (LiGermany
and Wilkinson, 1998). This function of NMD as a quality
control of gene expression has also been implicated in
the disposal of nonfunctional by-products of normal
The robustness of biological systems depends on the
RNA processing.
function of proofreading mechanisms against operating
NMDÐAn Enigma in RNA Metabolism
errors. Studies in yeast and of human genetic disorders
NMD has captured much attention as one of the most
have lead the way to a conserved surveillance mecha-
enigmatic processes in RNA metabolism. Basically, a cell
nism that identifies faulty open reading frames (ORFs)
must discriminate the normal stop codon from a prema-
and eliminates ªimperfect messagesº that contain pre- ture one (discrimination phase). Subsequently, a PTC-
mature translation termination codons (PTCs) and code mutated mRNA is committed to a pathway (commitment
for nonfunctional or even harmful polypeptides; this mech- phase) that ultimately results in its degradation (degra-
anism has been termed nonsense-mediated mRNA decay dation phase). NMD in yeast is becoming increasingly
(NMD). well understood (Jacobson and Peltz, 1996; Ruiz-Eche-
The Biological and Medical Importance of NMD varria et al., 1998). By contrast, diverse models are con-
It was noticed in 1979 that PTC mutations of the yeast sidered for mammalian NMD (Maquat, 1995; Li and Wil-
ura3 gene destabilized the encoded mRNA (Losson and kinson, 1998). We will describe some key findings from
Lacroute, 1979). In the same year, the level of PTC- the mammalian and yeast systems and will suggest that
mutated b-globin mRNA from a thalassemia patient was most of the available evidence can be integrated into a
reported to be very low (Chang and Kan, 1979), fore- common model.
shadowing the broad phylogenetic distribution of NMD Mammalian NMD: Nuclear Aspects
and its role in human genetic disorders. The vast major- There is little doubt that mammalian NMD is a posttran-
ity of b-thalassemia heterozygotes are phenotypically scriptional mechanism that involves the nucleus. Two
healthy, whereas homozygotes suffer from a severe ane- types of alterations have been described: the abnormal
mia. Normal erythropoiesis requires a/b-globin chain splicing of pre-mRNAs, and the degradation of spliced
balance. In heterozygotes, the relative excess of insolu- mRNAs. Both alterations have been referred to as NMD.
ble a-globin chains are degraded but accumulate in Regarding the first, examples of both nonsense-associ-
homozygotes to damage the erythroid precursors. PTC ated alternative splicing (e.g., fibrillin mRNA) and of in-
mutations in the two 59 proximal exons of the b-globin tron retention (e.g., Igk RNA) have been investigated. In
gene are common, and the mRNA is subjected to NMD. these examples, PTCs are associated with an effect
In contrast, a dominant form of inheritance is associated on splicing, for which we suggest the term ªnonsense-
with a rare nonsense mutation in the last exon. This associated altered splicingº (NAS). NAS is intriguing,
PTC-mutated mRNA escapes NMD, is normally abun- because it suggests that the sense of a pre-mRNA can
dant, and is translated (Hall and Thein, 1994). This addi- be interpreted by a nuclear reading frame scanner be-
tional burden causes the proteolytic system of the ery- fore splicing (Li and Wilkinson, 1998). Other alternative,
throid precursor cells to fail, which results in the
precipitation of insoluble globin chains and in severe
dyserythropoiesis. Therefore, NMD helps to protect mil-
lions of b-thalassemia heterozygotes from significant
disease. NMD is not restricted to b-globin mRNAs and
has been reported in many other human diseases.
The beneficial effect of NMD has also been docu-
mented for the C. elegans myosin heavy chain unc-
54 mRNA (Pulak and Anderson, 1993). Heterozygous
worms are phenotypically normal, whereas homozy-
gotes display striking abnormalities of muscle architec-
ture and function. However, when NMD is inactivated
by mutations of the smg genes (suppressor with mor-
phogenetic effects on genitalia), otherwise normal worms Figure 1. Nonsense-Mediated Decay: An Important Surveillance
Mechanism and an Enigma in RNA Metabolismthat are heterozygous for some critical unc-54 mutations
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NMD appears to affect fully spliced mRNAs (Zhang et
al., 1998b), the information provided by splicing must
affect a postsplicing process.
An intriguing aspect of many cases of NMD in verte-
brate cells relates to the observation that the reduction
of mRNA levels is already apparent for the nucleus-
associated RNA (Maquat, 1995; Li and Wilkinson, 1998).
This might suggest that the PTC-mutated mRNA is al-
ready degraded in the nucleus. On the other hand, there
is no positive evidence to suggest that the postsplicing
step(s) involved in NMD occurs within the nucleus ex-
Figure 2. Intron-Related Positional Boundaries for Mammalian NMD cept for the apparent reduction of nucleus-associated
The mapped boundaries for NMD of three mammalian mRNAs are mRNA.
indicated. Red, PTCs in this region cause NMD; green, PTCs in this Mammalian NMD: Cytoplasmic Aspects
region do not trigger NMD. Note that the RNAs are not drawn to
To examine whether NMD leads to a reduction of the cy-scale. No positional boundaries similar to those shown here have
toplasmic- or nucleus-associated forms of PTC-mutatedbeen found for the TCRb mRNA.
mRNAs, various protocols have been employed to cleanly
separate nuclei from cytoplasm. Nucleus-associated
more conventional explanations for NAS have also been RNA can be located within the nucleoplasm, associated
documented in some cases where PTC mutations inacti- with the nuclear pore, or be almost fully exported and
vate exonic splice enhancers to cause exon skipping not yet released from the nucleus. By contrast, the RNA
(Shiga et al, 1997). How might one distinguish between in the supernatant is considered to be cytoplasmic.
mechanisms for nuclear PTC recognition and other Hence, the definition of nuclear association is opera-
events that cause alterations of splicing? If NAS relied tional. Alternatively, a functional definition can be ap-
on the nuclear interpretation of the ORF, one would plied: mRNA that is translated by ribosomes is consid-
predict that the three nonsense mutations, but not the ered to be cytoplasmic. However, most experiments
60 remaining mutations of an affected triplet, would alter employing such a functional definition fail to distinguish
splicing. One might also expect that a NAS-associated traditional cytoplasmic ribosomes from a ribosome-like
nuclear scanning mechanism would not be restricted to nuclear scanner as suggested for NAS.
a few codons in a given exon. Such critical predictions Initially, NMD was thought to be a consequence of
for the function of a notional ªnuclear scannerº in NAS the lack of ribosomes that could protect the mRNA
remain to be more fully explored. downstream from a nonsense codon. The available evi-
By contrast to NAS, no splicing alterations are found dence indicates now that a mechanism with the hall-
in the second type of PTC-induced RNA processing marks of ribosomal translation is actually required for
abnormality, nonsense-mediated decay (NMD) senso NMD (Maquat, 1995; Li and Wilkinson, 1998). However,
strictu. Here, spliced mRNA is subject to degradation. it could not be excluded that this mechanism is mediated
Even if NMD does not exhibit effects on splicing, there by a hypothetical nuclear cousin of the cytoplasmic
is mounting evidence for a role of splicing. Early on, it translation apparatus. The cytoplasmic binding of iron
was found that nonsense codons located toward the 39 regulatory proteins (IRPs) to iron-responsive elements
end of the ORF rarely elicit NMD. For some cases, this to regulate the translation of a PTC-mutated b-globin
positional bias has now been shown to be defined by mRNA has been used as an approach to avoid such
the relative position of the PTC to a boundary ≈50 nt 59 ambiguities. IRPs are spatially restricted to the cyto-
of the final exon/intron junction (Figure 2). PTCs 59 to plasm (Thermann et al., 1998) and thus served as a
this boundary subject the mRNA to NMD, whereas specific tool to inhibit cytoplasmic translation without
mRNAs with a PTC 39 to this boundary are usually stable affecting the activity of a notional ribosome-related nu-
(Thermann et al., 1998; Zhang et al., 1998a, 1998b). The clear scanner. NMD was found to be specifically abro-
importance of splicing for NMD has been documented gated by IRP-mediated translational repression, reveal-
by the insertion of an intron downstream from the normal ing the requirement of cytoplasmic translation for NMD
stop codon. This manipulation subjects mRNAs without (Thermann et al., 1998). If NMD of nucleus-associated
a PTC to NMD (Carter et al., 1996; Thermann et al., 1998). RNA generally requires translation by cytoplasmic ribo-
The hypothesis that cells can distinguish PTCs from somes, one must ask about the kinetic relationship be-
normal stop codons by the presence or absence of a tween the first ªtranslational encounterº of an mRNA
downstream intron is reinforced by the observation that vis-aÁ -vis its release from the nucleus. mRNAs can be
39 UTR introns are rare (Hawkins, 1988) and usually lo- translated while still being exported from the nucleus
cated closer to the stop codon than the positional and do not need to be translated in order to be exported.
boundary mentioned above (Nagy and Maquat, 1998). However, the important general question concerning the
While these results clearly implicate splicing in NMD, kinetic relationship between the release of an mRNA
splicing of downstream introns does not seem to always from nuclear association and its first translation is cur-
be required (e.g., Zhang et al., 1998b). Also, downstream rently unanswered.
introns are not always sufficient to specify NMD (e.g., Insights from Yeast
male sex lethal mRNA in Drosophila embryos). Splicing Compared to mammalian cells, the understanding of the
thus plays a clear role in specifying NMD, even if it is discrimination, commitment, and degradation steps of
NMD in yeast is further advanced. Similar to mammalianneither absolutely necessary nor always sufficient. Since
Minireview
309
Figure 3. Model for NMD by a Common Post-
termination Surveillance Mechanism in Mam-
mals and Yeast
Hypothetical downstream commitment fac-
tors (DCFs) are directed to the mRNAs either
by the yeast downstream sequence element
(DSE) or by mammalian splicing. Subsequent
to DCF binding (step 2), both yeast and mam-
malian mRNAs are suggested to follow similar
pathways. Hence, they are depicted on top
of each other from step 3 onward. DCF shown
in orange symbolizes an uncommited state.
Following an encounter with elongating ribo-
somes, DCF shown in green indicates lack of
potential to cause NMD. Commitment to NMD
is triggered when DCF (now red) is recognized
by the posttermination surveillance complex
(shown as an eye). When the mRNA is not
translated, DCFs do not trigger NMD (orange)
and may eventually dissociate (arrows). PTC,
premature termination codon; DCP1, decap-
ping enzyme (saw); Xrn1, 59→39 exonuclease
(packman).
cells, yeast mRNAs containing PTCs are often degraded nuclear localization signal (Jacobson and Peltz, 1996),
supporting the overall view that yeast NMD is a cyto-faster than their wild-type counterparts (Jacobson and
Peltz, 1996). In contrast to mammalian cells, there are plasmic process.
A common pathway for the degradation of wild-typeno reported effects of PTCs on splicing (NAS), and the
important role of cytoplasmic translation is well ap- mRNAs in yeast commences with the deadenylation of
the mRNAs, followed by decapping by the enzymepreciated.
While PTCs in mammalian mRNAs can be identified Dcp1p and subsequent 59 to 39 degradation by the exo-
nuclease Xrn1p (Beelman et al., 1996). The degradationby the presence of a downstream intron, yeast discrimi-
nates premature from normal stop codons by exonic phase of NMD in yeast enters this pathway in a deadeny-
lation-independent way. How the commitment to NMDdownstream sequence elements (DSE). Stop codons
followed by a DSE within approximately 200 nucleotides triggers the activity of Dcp1p is still unknown. Yeast
NMD appears to differ from mammalian NMD with re-are interpreted as PTCs if the DSE is encountered by a
posttermination surveillance complex and not by elon- gard to the involvement of splicing, the role of DSEs
and introns, and the apparent lack of nuclear associationgating ribosomes that have reinitiated translation up-
stream of the DSE (Ruiz-Echevarria et al., 1998). PTC- of the yeast RNAs undergoing degradation.
A Perfect Model?mutated yeast mRNAs can also escape degradation
when a stabilizer element (STE) is inserted between the Using the information from yeast as a conceptual tem-
plate to model NMD in mammalian cells, both pathwaysPTC and the DSE, or occurs upstream of the PTC. Fi-
nally, translation elongation is dispensible for NMD in can be merged. With reference to the findings in yeast,
we refer to this proposed pathway as a ªpostterminationyeast, because the presence of a cassette consisting
of an AUG initiation codon immediately followed by stop surveillance modelº (Ruiz-Echevarria et al., 1998; see also
Li and Wilkinson, 1998; Thermann et al., 1998; Zhang etcodons upstream of a DSE suffices to subject an mRNA
to NMD (Ruiz-Echevarria et al., 1998). Two cis-acting al., 1998b).
Mammalian NMD exploits splicing as a means to intro-sequences, a termination codon and a DSE, thus direct
mRNAs to NMD in yeast, unless a dominant cis-acting duce a downstream point of reference to discriminate
between PTCs and normal stop codons (Figure 3, stepstabilizer sequence is positioned between the two (Fig-
ure 3) or upstream of the PTC. 1). Some serine-arginine (SR)-rich proteins bind to pre-
mRNAs during splicing and remain associated with theFurther support for the importance of translation (ter-
mination) comes from the analysis of Upf (up frameshift) exonic splice product (Caceres et al., 1998). Tagging of
exonic splice junctions by SR or other nuclear proteinsproteins that are required for NMD but not other mRNA
degradation pathways in yeast. These proteins form a during and after export of the mRNA into the cytoplasm
could represent a functional correlate to the DSE andcomplex that promotes efficient translation termination
and interacts with the termination factors eRF1 and (still hypothetical) DSE-binding proteins in yeast (Figure
3, step 2). In both systems, such proteins would serveeRF3 (Czaplinski et al., 1998). Analysis of Upf1p mutants
led to the hypothesis that a Upf protein±containing sur- as downstream commitment factors (DCFs) (Figure 3,
step 3). DSE-like sequences that bind DCFs in a splicing-veillance complex is recruited to mRNAs when the ribo-
some is complexed with the translation termination ma- independent way may also exist in mammalian cells
and explain cases where PTCs cause NMD without thechinery. It was also shown that a dominant-negative
mutant of Upf2p fails to block NMD when fused to a presence of a downstream intron.
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Hall, G.W., and Thein, S. (1994). Blood 83, 2031±2037.DCFs encountered by elongating ribosomes during
Hawkins, J.D. (1988). Nucleic Acids Res. 16, 9893±9908.the first translation of an mRNA before (NMD of nucleus-
Jacobson, A., and Peltz, S.W. (1996). Annu. Rev. Biochem. 65,associated RNA) or after (NMD of cytoplasmic RNA) its
693±739.release from the nuclear fraction will be interpreted to
Li, S., and Wilkinson, M.F. (1998). Immunity 8, 135±141.represent a spliced-out intron or a DSE within the ORF
Losson, R., and Lacroute, F. (1979). Proc. Natl. Acad. Sci. USA 76,and thus not cause NMD (Figure 3, step 4, left). Likewise,
5134±5137.lack of cytoplasmic translation before the dissociation
Maquat, L.E. (1995). RNA 1, 453±465.of DCFs would fail to cause commitment to NMD (Figure
Nagy, E., and Maquat, L.E. (1998). Trends Biochem. Sci. 23, 198±199.3, step 4, right). By contrast, recognition of DCFs down-
Pulak, R., and Anderson, P. (1993). Genes Dev. 7, 1885±1897.stream of a stop codon by a posttermination surveillance
Ruiz-Echevarria, M.J., Gonzalez, C.I., and Peltz, S.W. (1998). EMBOcomplex commits the mRNA to the NMD pathway (Fig-
J. 17, 575±589.ure 3, step 4, middle; step 5). A cotransfected dominant-
Shiga, N., Takeshima, Y., Sakamoto, H., Inoue, K., Yokota, Y., Yoko-negative mutant of a human UPF1 homolog stabilized
yama, M., and Matsuo, M. (1997). J. Clin. Invest. 100, 2204±2210.NMD reporter constructs in mammalian cells, providing
Sun, X., Perlick, H.A., Dietz, H.C., and Maquat, L.E. (1998). Proc.evidence for the functional involvement of a Upf protein
Natl. Acad. Sci. USA 95, 10009±10014.in mammalian NMD (Sun et al., 1998). DCF recognition
Thermann, R., Neu-Yilik, G., Deters, A., Frede, U., Wehr, K., Hage-by a posttermination complex might trigger NMD, while
meier, C., Hentze, M.W., and Kulozik, A.E. (1998). EMBO J. 17, 3484±
the encounter with elongating ribosomes would not. This 3494.
proposal would explain why translation reinitiation 39 of
Zhang, J., and Maquat, L.E. (1997). EMBO J. 16, 826±833.
a PTC abrogates NMD in mammalian cells (Zhang and
Zhang, J., Sun, X., Qian, Y., LaDuca, J.P., and Maquat, L.E. (1998a).
Maquat, 1997), as seen in yeast. Furthermore, the exis- Mol. Cell. Biol. 18, 5272±5283.
tence of a correlate to the yeast STE in animal cells might Zhang, J., Sun, X., Qian, Y., and Maquat, L.E. (1998b). RNA 4,
explain why some mRNAs with introns downstream of 801±815.
a stop codon excape NMD. Little information is currently
available for the degradation phase of mammalian NMD
(Figure 3, steps 6 and 7). Based on yeast NMD, the post-
termination surveillance model suggests the involve-
ment of putative Dcp1p and Xrn1p homologs.
Is the posttermination surveillance model a perfect
model to explain NMD as a quality control mechanism
for perfect messages in all eukaryotic cells? With regard
to mammalian cells, it remains to be determined. The
envisaged coupling between mRNA translation and
turnover bears provocative implications that reach be-
yond the understanding of NMD: DCF-binding se-
quences in the 39 UTR of mRNAs would be predicted to
act as translation-dependent ªinstability determinants,º
able to affect the turnover of wild-type mRNAs. The
identification of trans-acting factors that mediate mam-
malian NMD will shed light on the mechanistic similari-
ties and differences with yeast, and it will permit a direct
test of whether NMD and the turnover of some wild-
type mRNAs share common factors. For yeast, the
mechanistic understanding is further advanced, and the
time seems ripe to unravel the composition and function
of the surveillance complex biochemically and to identify
factors at the juncture between DSE recognition and
the activation of the decapping enzyme Dcp1p. Once
more, yeast may hold valuable insights into mechanisms
that operate in the context of human genetic diseases.
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